What is the typical presentation—including chief complaint, history of present illness, physical exam findings, laboratory results, and signature signs—of primary amebic meningoencephalitis caused by Naegleria fowleri in a previously healthy child or young adult male after recent warm freshwater exposure?

Typical Presentation of Primary Amebic Meningoencephalitis (PAM) from Naegleria fowleri

Primary amebic meningoencephalitis presents as a fulminant, rapidly progressive meningoencephalitis that is clinically indistinguishable from bacterial meningitis but progresses to death within a median of 5 days from presentation, with mortality exceeding 95%. 1

Chief Complaint (CC)

• Severe frontal headache (most common initial symptom)
• Fever (typically 38.5°C or higher)
• Nausea and vomiting
• Altered mental status (in later presentations) 2, 3, 4, 5

History of Present Illness (HPI)

Critical Exposure History

The pathognomonic historical feature is warm freshwater exposure 1-9 days before symptom onset, typically:

• Swimming/bathing in warm freshwater lakes, ponds, or rivers during summer months
• Hot spring bathing
• Water play on lawn water slides
• Nasal lavage with contaminated water (neti pots, ritual nasal ablution)
• Municipal water supply exposure 1, 2, 6

Temporal Progression

The disease follows a characteristic biphasic pattern 3:

Early Phase (Days 1-3):

• Severe frontal headache
• High fever (often >38.5°C)
• Nausea and vomiting
• Neck stiffness/pain
• Altered sense of smell or taste (due to olfactory nerve involvement)

Late Phase (Days 3-5):

• Rapid neurological deterioration
• Altered mental status progressing to coma
• Seizures (generalized tonic-clonic)
• Visual and auditory hallucinations
• Focal neurological deficits (hemiparesis)
• Behavioral changes
• Photophobia 2, 3, 7, 8

Demographics

• Median age: 12 years (83% are ≤18 years old)
• Male predominance: 76%
• Previously healthy children and young adults
• Occurs predominantly in summer months 3

Physical Examination (PE)

Vital Signs

• High fever (38.5-40°C)
• Tachycardia
• Signs of increased intracranial pressure in later stages 2, 4

Neurological Examination

• Meningismus (neck stiffness, positive Kernig's and Brudzinski's signs)
• Altered mental status ranging from lethargy to coma
• Focal neurological deficits: hemiparesis, cranial nerve palsies
• Seizure activity
• Periorbital edema (from increased intracranial pressure)
• Inability to stand or walk (ataxia)
• Papilledema (late finding) 2, 3, 4, 5

Laboratory Findings

Cerebrospinal Fluid (CSF) - The Key Diagnostic Specimen

CSF findings mimic bacterial meningitis but with critical distinguishing features 3:

• Opening pressure: Markedly elevated (often >250 mm H₂O)
• White blood cell count: Elevated with neutrophilic predominance
  • Median: 2,400 cells/μL (range: 5-26,000 cells/μL)
  • Predominantly neutrophils (not lymphocytes)
• Glucose: Markedly decreased
  • Median: 23 mg/dL (range: 1-92 mg/dL)
• Protein: Markedly elevated
  • Median: 365 mg/dL (range: 24-1,210 mg/dL)
• Gram stain: Negative for bacteria
• Bacterial cultures: Negative (critical clue when patient fails to respond to antibiotics)

Signature Diagnostic Finding: Motile Trophozoites in CSF

The pathognomonic finding is visualization of motile amoebic trophozoites 9, 2, 3, 4:

• Fresh CSF wet mount examination (must be performed immediately on warm CSF)

  • Shows actively motile trophozoites with characteristic amoeboid movement
  • Trophozoites are 10-35 μm in diameter
  • Display broad, blunt pseudopodia
  • May be mistaken for leukocytes if not examined carefully for motility

• Wright-Giemsa staining of CSF sediment

  • Reveals amoebic trophozoites with visible nuclei

• Metagenomic next-generation sequencing (mNGS) of CSF

  • Confirms Naegleria fowleri DNA (copy numbers typically >10⁵ copies/mL)
  • Increasingly used for rapid diagnosis 2, 8, 6

Blood Tests

• Leukocytosis with left shift
• Elevated inflammatory markers (CRP, ESR)
• Otherwise nonspecific 2, 6

Neuroimaging Findings

MRI Brain (Preferred)

Imaging is abnormal in approximately 75% of cases but is NOT diagnostic 3:

• Gray matter involvement (cortical and deep gray matter)
• Bilateral cortical-subcortical hyperintense lesions on T2/FLAIR
  • Predominantly involving frontal, temporal, and insular regions
  • Basal ganglia and thalamic involvement
• Obliteration of subarachnoid spaces around the midbrain
• Microhemorrhages (necrotizing component)
• Hydrocephalus (late finding)
• Mass effect with herniation (terminal stage)
• Enhancement of leptomeninges and gray matter 3, 7, 8

Critical caveat: Early imaging may be completely normal, particularly in the first 24-48 hours, despite fulminant clinical progression 8

CT Brain

• Often shows only nonspecific findings
• May demonstrate obliteration of cisterns
• Cerebral edema
• Less sensitive than MRI 2, 4

Signature Clinical Signs

The "Brain-Eating Amoeba" Triad

1. Recent warm freshwater exposure (1-9 days prior)
2. Fulminant meningoencephalitis mimicking bacterial meningitis
3. Failure to respond to standard antibiotic therapy with rapid deterioration 1

Diagnostic Red Flags

• Altered sense of smell/taste (olfactory nerve invasion - the amoeba enters through the cribriform plate)
• Negative bacterial cultures despite purulent CSF
• Rapid progression to coma within 24-72 hours
• Death from cerebral edema/herniation within median 5 days 1, 3

Geographic and Seasonal Distribution

Geographic Pattern

• Historically: Southern-tier U.S. states (Texas, Florida, Arizona, California)
• Expanding northward: Recent cases in Minnesota, Kansas, Indiana, Vermont, New Hampshire
• Related to warming temperatures allowing thermophilic organism growth 1, 3, 6

Seasonal Pattern

• Predominantly summer months (June-September)
• Correlates with warm water temperatures (>25°C/77°F) optimal for N. fowleri growth 1

Critical Diagnostic Pitfalls

PAM is diagnosed pre-mortem in only 27% of cases 1, 3. Common reasons for missed diagnosis:

1. Failure to obtain detailed water exposure history - specifically ask about:

   • Swimming/diving in warm freshwater
   • Hot spring bathing
   • Nasal irrigation practices
   • Water play activities 6

2. Mistaking trophozoites for leukocytes on CSF examination

   • Must examine fresh, warm CSF immediately for motility
   • Trophozoites lose motility as CSF cools 9, 4

3. Assuming bacterial meningitis based on neutrophilic CSF

   • Key difference: negative Gram stain and cultures
   • Failure to improve on antibiotics should trigger reconsideration 1

4. Relying on normal early imaging to exclude diagnosis

   • MRI may be normal in first 24-48 hours despite fulminant clinical course 8

Outcome and Prognosis

Mortality exceeds 95%, with death typically occurring within 5 days of presentation from cerebral edema and herniation 1, 3. Only 3 survivors were documented in the U.S. before 2013, with 2 additional pediatric survivors in 2013 following early treatment with miltefosine-containing regimens 1. Survival is contingent on early clinical suspicion and immediate initiation of anti-amoebic therapy 1.

When to Suspect PAM - Clinical Algorithm

Suspect PAM immediately when ALL of the following are present:

1. Acute meningoencephalitis with CSF findings resembling bacterial meningitis
2. History of warm freshwater exposure or nasal water contact within past 1-9 days
3. Negative Gram stain and bacterial cultures
4. Rapid neurological deterioration despite antibiotics

If PAM is suspected, contact CDC immediately at 770-488-7100 (24/7) for diagnostic assistance and access to miltefosine 3.